🇺🇸 FDA

Company profile · Sponsor

Lei

Lei Li

CE77BE8 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Lei (CE77BE8) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CE77BE8
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Chemotherapy plus apatinib

    Lei

    Recurrent Cervical Carcinoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Lei?

Lei (CE77BE8) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Lei sponsor?

We track 1 ClinicalTrials.gov-linked program for Lei, including Chemotherapy plus apatinib. Open each program for phase, modality, NCT IDs, and indication details.

Where does Lei company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.